New PAH pill shows promise in large trial
Disease control
Completed
This study tested a new medicine called ralinepag for people with pulmonary arterial hypertension (PAH), a serious lung condition that makes the heart work harder. About 687 adults with PAH took ralinepag or a placebo on top of their usual treatments. The goal was to see if ralin…
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC